280 related articles for article (PubMed ID: 12036683)
1. Additive intraocular pressure lowering effect of various medications with latanoprost.
O'Connor DJ; Martone JF; Mead A
Am J Ophthalmol; 2002 Jun; 133(6):836-7. PubMed ID: 12036683
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
Petounis A; Mylopoulos N; Kandarakis A; Andreanos D; Dimitrakoulias N
J Glaucoma; 2001 Aug; 10(4):316-24. PubMed ID: 11558817
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
Polo V; Larrosa JM; Gomez ML; Pablo L; Honrubia FM
Acta Ophthalmol Scand; 2001 Feb; 79(1):6-9. PubMed ID: 11167277
[TBL] [Abstract][Full Text] [Related]
5. Latanoprost versus combined timolol and dorzolamide.
Bron AM; Emmerich KH
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S148-54. PubMed ID: 12204712
[TBL] [Abstract][Full Text] [Related]
6. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
Simmons ST; Samuelson TW
Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
Simmons ST;
Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
[TBL] [Abstract][Full Text] [Related]
8. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
Gebhardt DO
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):275. PubMed ID: 10086159
[No Abstract] [Full Text] [Related]
9. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Simmons ST; Earl ML;
Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
Wang RF; Serle JB; Gagliuso DJ; Podos SM
J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
[TBL] [Abstract][Full Text] [Related]
11. Additive effect of latanoprost to the combination of timolol and dorzolamide.
Susanna R; Nicolela MT; Oga E
J Glaucoma; 2000 Apr; 9(2):183-6. PubMed ID: 10782630
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial.
Lee DA; Gornbein JA
J Glaucoma; 2001 Jun; 10(3):220-6. PubMed ID: 11442187
[TBL] [Abstract][Full Text] [Related]
13. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
García Sanchez J
Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.
Italian Multicentric Open Randomized Study under the aegis of A.I.S.G.: Final Results and Official Report
Acta Ophthalmol Scand Suppl; 2000; (232):49-50. PubMed ID: 11235535
[No Abstract] [Full Text] [Related]
16. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
Hoyng PF; Rasker MT
Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2138-41. PubMed ID: 9856229
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.
Kimal Arici M; Topalkara A; Güler C
Int Ophthalmol; 1998; 22(1):37-42. PubMed ID: 10090447
[TBL] [Abstract][Full Text] [Related]
18. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
[TBL] [Abstract][Full Text] [Related]
19. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]